Child / Adolescent - Anxiety
Stephen Whiteside, Ph.D. (he/him/his)
Professor
Mayo Clinic
Rochester, Minnesota, United States
Wendy Silverman, ABPP, Ph.D. (she/her/hers)
Professor
Yale School of Medicine Child Study Center
New Haven, Connecticut, United States
Maaike Nauta, M.S., Ph.D. (she/her/hers)
Professor
University of Groningen, the Netherlands
Groningen, Groningen, Netherlands
Chloe Chessell, Ph.D. (she/her/hers)
University of Oxford
Oxford, England, United Kingdom
Jennifer Hudson, Ph.D. (she/her/hers)
Professor
Black Dog Institute
Sydney, New South Wales, Australia
Eli Lebowitz, Ph.D.
Associate Professor
Yale Child Study Center
New Haven, Connecticut, United States
Lilianne Gloe, Ph.D. (she/her/hers)
Child Psychology Fellow
Mayo Clinic
Rochester, Minnesota, United States
Anxiety disorders are the most common psychiatric disorders in youth, with prevalence estimates as high as 15 to 20% and are associated with significant and sustained impairment. With over 40 randomized controlled trials spanning three decades, cognitive behavioral therapy (CBT) is the most researched and first line intervention for childhood anxiety disorders (CADs). Extant evidence supporting the use of CBT includes findings that it is more effective than waitlist control and pill-placebo as well as equivalent to medication. Further, CBT has been used as the standard for demonstrating outcome equivalence and has demonstrated partial superiority over active controls. Despite the substantial success of CBT, additional improvements to treatment for CADs are needed. Specifically, more than 50% of patients remain symptomatic after a course of CBT and CBT has not demonstrated superiority over treatment as usual. Additionally, the length of traditional CBT of 12 or more sessions exceeds the average number of sessions attended in real-world settings, questioning the clinical utility/applicability of traditional CBT. As such, to improve the lives of youth with CADs, innovative treatments need to be developed that offer greater symptom relief more quickly.
The current symposium presents a path toward increasing the effectiveness, efficiency, and accessibility of therapy for CADs through an emphasis on exposure, parent involvement, and technology. The first presentation demonstrates the distinct importance of in-session exposure and parent involvement through a randomized controlled microtrial of in-person therapy. The second presentation demonstrates the potential to increase accessibility by presenting the results of a brief online treatment program delivered in routine clinical practice and by identifying barriers and facilitators to the implementation of this intervention in routine services using implementation science frameworks. The third presentation demonstrates pilot and factorial design studies on the use of technology to optimize the delivery and impact of exposure treatment. The fourth study presents data from a clinical research program demonstrating the effectiveness of a parent-based treatment. The fifth presentation demonstrates that parent-coached exposure can improve treatment in a randomized controlled trial. Finally, the discussant will explore the implications of the presented work for optimizing child anxiety treatment.
Speaker: Maaike Heleen Nauta, M.S., Ph.D. (she/her/hers) – University of Groningen, the Netherlands
Co-author: Rachel de Jong, PhD (she/her/hers) – University of Groningen, the Netherlands
Co-author: Miriam Lommen, PhD (she/her/hers) – University of Groningen, the Netherlands
Co-author: Rowella Kuijpers, PhD (she/her/hers) – Radboud University
Co-author: Lisanne Stone, PhD – Tilburg University
Co-author: Wiljo van Hout, PhD – University of Groningen
Co-author: Peter de Jong, Ph.D. – University of Groningen
Speaker: Chloe Chessell, Ph.D. (she/her/hers) – University of Oxford
Speaker: Jennifer L. Hudson, Ph.D. (she/her/hers) – Black Dog Institute
Co-author: Chloe Lim, PhD (she/her/hers) – Black Dog Institute
Co-author: Wenting Chen, Ph.D. (she/her/hers) – Black Dog Institute
Co-author: Emma McDermott, BPsych(Hons) (she/her/hers) – Black Dog Institute
Co-author: Gemma Sicouri, PhD (she/her/hers) – Black Dog Institute
Speaker: Eli R. Lebowitz, Ph.D. – Yale Child Study Center
Speaker: Lilianne M. Gloe, Ph.D. (she/her/hers) – Mayo Clinic
Co-author: Lilianne M. Gloe, Ph.D. (she/her/hers) – Mayo Clinic
Co-author: Stephen P H Whiteside, Ph.D. (he/him/his) – Mayo Clinic
Co-author: Bridget K. Biggs, ABPP, Ph.D., Other – Mayo Clinic